title: Are country reputations for good and bad leadership on AIDS deserved? An exploratory quantitative analysis.
abstract: Some countries (e.g. Brazil) have good reputations on AIDS policy, whereas others, (notably South Africa) have been criticized for inadequate leadership. Cross-country regression analysis reveals that these 'poster children' for AIDS leadership have indeed performed better or worse than expected given their economic and institutional constraints and the demographic and health challenges facing them. Regressions were run on HAART coverage (number on highly active antiretroviral therapy as percentage of total need) and MTCTP coverage (pregnant HIV+ women accessing mother-to-child-transmission prevention services as percentage of total need). Brazil, Cambodia, Thailand and Uganda (all of whom have established reputations for good leadership on AIDS performed consistently better than expected-as did Burkina-Faso, Suriname, Paraguay Costa Rica, Mali and Namibia. South Africa, which has the worst reputation for AIDS leadership, performed significantly below expectations-as did Uruguay and Trinidad and Tobago. The paper thus confirms much of the conventional wisdom on AIDS leadership at country level and suggests new areas for research.
authors.affiliation: AIDS and Society Research Unit, University of Cape Town, Rondebosch, Cape Town, South Africa. nicoli.nattrass@gmail.com
authors.forename: Nicoli
authors.initials: N
authors.lastname: Nattrass
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D005260:Female; D014943:Global Health; D006291:Health Policy; D006801:Humans; D007391:International Cooperation; D007857:Leadership; D008297:Male; D011634:Public Health; D011635:Public Health Administration; D012044:Regression Analysis; D012959:Socioeconomic Factors; D013019:South Africa
chemical_list: D019380:Anti-HIV Agents